Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Plumas

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Leukemia & Lymphoma|June 1, 2000
From the study of tumor cell immunogenicity to the generation of antitumor cytotoxic cells in non-Hodgkin's lymphomasL Chaperot, M C Jacob, J P Molens, et al.
Blood|May 16, 1998
Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosisJ Plumas, M C Jacob, L Chaperot, et al.
Leukemia|July 29, 2005
Mesenchymal stem cells induce apoptosis of activated T cellsJ Plumas, L Chaperot, M-J Richard, et al.
Cell Death and Differentiation|July 30, 2005
E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short)C Salon, B Eymin, O Micheau, et al.
La Revue De Medecine Interne|March 25, 2011
[GENiusVac, a novel antitumor vaccine strategy based on allogeneic plasmacytoid dendritic cells]C Aspord, J Charles, M-T Leccia, et al.
European Cytokine Network|January 1, 1992
Induction of CD23, CD25 and CD4 expression on an eosinophilic cell line (EoL-3) by interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-5 (IL-5)J Chihara, V Gruart, J Plumas, et al.
Experimental Hematology|March 25, 1999
Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomasL Chaperot, J Plumas, M C Jacob, et al.
European Journal of Immunology|December 1, 1995
Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cellsJ Plumas, L Chaperot, M C Jacob, et al.
Leukemia|February 24, 2001
Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell lineM Irisarri, J Plumas, T Bonnefoix, et al.
Cytotherapy|June 19, 2004
Preparation of purified lymphoma cells suitable for therapyG Lui, O Manches, L Chaperot, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|June 1, 2000
From the study of tumor cell immunogenicity to the generation of antitumor cytotoxic cells in non-Hodgkin's lymphomasL Chaperot, M C Jacob, J P Molens, et al.
Blood|May 16, 1998
Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosisJ Plumas, M C Jacob, L Chaperot, et al.
Leukemia|July 29, 2005
Mesenchymal stem cells induce apoptosis of activated T cellsJ Plumas, L Chaperot, M-J Richard, et al.
Cell Death and Differentiation|July 30, 2005
E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short)C Salon, B Eymin, O Micheau, et al.
La Revue De Medecine Interne|March 25, 2011
[GENiusVac, a novel antitumor vaccine strategy based on allogeneic plasmacytoid dendritic cells]C Aspord, J Charles, M-T Leccia, et al.
European Cytokine Network|January 1, 1992
Induction of CD23, CD25 and CD4 expression on an eosinophilic cell line (EoL-3) by interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-5 (IL-5)J Chihara, V Gruart, J Plumas, et al.
Experimental Hematology|March 25, 1999
Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomasL Chaperot, J Plumas, M C Jacob, et al.
European Journal of Immunology|December 1, 1995
Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cellsJ Plumas, L Chaperot, M C Jacob, et al.
Leukemia|February 24, 2001
Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell lineM Irisarri, J Plumas, T Bonnefoix, et al.
Cytotherapy|June 19, 2004
Preparation of purified lymphoma cells suitable for therapyG Lui, O Manches, L Chaperot, et al.
Pageof 4